Resources Contact Us Home
20-HETE antagonists and agonists

Image Number 13 for United States Patent #6395781.

20-HETE agonists and antagonists are disclosed along with therapeutic applications. In a preferable form of the invention, the 20-HETE agonists are selected from the group consisting of 21-hydroxyheneicosa-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid, 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid and 20-,21-dimethyl 20-HETE. Preferable 20-HETE antagonists include 5(S)-HETE, 15(S)-HETE, 19(S)-HETE, 19-hydroxynonadeca-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid and 20-hydroxyeicosa 6(Z),15(Z)-dienoic acid.

  Recently Added Patents
Opioid-ketamine and norketamine codrug combinations for pain management
Reframing circuitry with virtual container drop and insert functionality to support circuit emulation protocols
Wake-up radio system
Solid-state imaging apparatus
Low offset, fast response voltage controlled current source and controlling method thereof
3D IC method and device
Conductor-mixed active electrode material, electrode structure, rechargeable battery, and manufacturing method of conductor-mixed active electrode material
  Randomly Featured Patents
Motorcycle helmet cover
Damper device
Spectral domain optical coherence tomography system
Optical coupler having a tapered fused region
Signal processing device for optical pick-up and a semiconductor device for the optical pick-up
Fluid sampler pouch with internal supportive structure
Cross-linked amide/olefin polymeric laminates
Hardware simulation accelerator design and method that exploits a parallel structure of user models to support a larger user model size
Device for the support of an absorbent article
Method for manufacturing photographic film and photographic film cassette